On September 7, 2021 Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer, reported the company will participate in three investor conferences in September 2021 (Press release, Sierra Oncology, SEP 7, 2021, View Source [SID1234587331]). Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra Oncology will provide a company update at the HC Wainwright 23rd Annual Global Investment Conference and the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit. He will participate in a fireside chat discussion at the 2021 Cantor Virtual Global Healthcare Conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Conference: HC Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13, 2021
Time: On demand viewing beginning at 7:00 am ET

Conference: Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
Date: Tuesday, September 21, 2021
Time: Presentation beginning at 2:05 pm ET

Conference: 2021 Cantor Virtual Global Healthcare Conference
Date: Tuesday, September 28, 2021
Time: Fireside chat beginning at 4:00 pm ET
All three presentations will be webcast and available at the times noted above on the Investors section of Sierra’s corporate website in the Events & Webcast tab.